Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Afamelanotide (Scenesse, Clinuvel Pharmaceuticals) is a linear MC1R selective tridecapeptide, approved by the FDA on October 8, 2019, and by the EMA on December 22, 2014, exclusively for the treatment of erythropoietic protoporphyria (EPP) in adults
Ice crystal formation during freezing physically disrupts peptide structure, and repeated freeze-thaw cycles compound this damage
What Your Skin Is Actually Telling You (And Why VISIA Can Read It) Your skin holds a lot more information than you can see in a mirror
Your sample is processed in UK-accredited laboratories, meaning your results are as accurate as those from your GPs surgery
We obtained a preparation (a mixture of tyndallized probiotics and their postbiotics) that was derived from the fermentation of Lacticaseibacillus paracasei in the presence of garlic extract and senna leaf
